Biotech Week Boston to Explore the Impact of a Clinton or Trump Presidency on the Biotech, Pharmaceutical Industries

Share Article

Moderated by STAT News, panel of industry leaders will discuss what the upcoming election means for the future of biotech and pharma

Biotech Week Boston (BWB), where the heart, technology and business of science converge, has confirmed that Rick Berke, executive editor of STAT, will moderate a politically charged expert panel discussion, “President Clinton or President Trump: What Our Next President Will Mean for Biotech and Pharma,” on Thursday, Oct. 6 at 5 p.m.

The inaugural Biotech Week Boston conference takes place Oct. 4-7 at the Boston Convention and Exhibition Center. The conference is chiefly interested in the forces of change driving the evolution of the technology and business of science to better meet the needs of patients in a value-based model. With a new President of the United States being sworn in next January, this highly anticipated one-hour political discussion boasts a distinguished panel of experts which includes;

  • Mason Tenaglia, vice president, Payer and Managed Care Insights, IMS Institute for Healthcare Informatics;
  • Dr. David Meeker, executive vice president and head of Sanofi Genzyme;
  • Kathleen Weldon Tregoning, senior vice president of Corporate Affairs, Biogen;
  • Damian Garde, national biotech reporter, STAT; and
  • Dylan Scott, Washington correspondent, STAT.

"Whether Trump or Clinton, the next president has the potential to tremendously impact the health, medicine, and life science arenas," said Rick Berke, Executive Editor, STAT. "By the time this panel takes place in October, our discussion will be all the more critical. We're thrilled to be a part of it, and we're expecting memorable insights from our experienced and wide-ranging roster of panelists."

“With such a terrific line-up of exhibitors and attendees at this year's Biotech Week Boston, our keynote speakers and panelists complement the world-class standards we’ve worked hard to develop over the years,” explained Russ Pratt, group portfolio director, KNect365, organizer of the event. “Importantly, Biotech Week Boston breaks down silos within companies, the value chain and industry to unlock greater collaboration between manufacturing, bioprocessing, clinical trials and regenerative medicine with the goal of getting new treatments to patients faster.”

About Biotech Week Boston:
Biotech Week Boston, where the heart, technology, and business of science converge, is the primary destination where passionate scientists and innovators meet to partner and share groundbreaking data, research and ideas. Register before September 28th to save $100 on admission:

About STAT:
STAT ( is a new national publication focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features. We tell our stories from the places that matter to our readers – research labs, hospitals, executive suites, and political campaigns. Based in Boston, STAT also has bureaus in Washington, New York, San Francisco, Los Angeles, and Cleveland. The team includes talented writers, editors, and producers capable of the kind of explanatory journalism that complicated science issues demand.

Follow Biotech Week Boston on Twitter: @BiotechWkBoston and #BIOTECHWEEKBOSTON

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Cassidy Hark
+1 617.692.0520
Email >
Visit website